Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Basiliximab Maintenance in Ulcerative Colitis

This study has been terminated.
(lack of efficacy)
Information provided by:
Cerimon Pharmaceuticals Identifier:
First received: February 2, 2010
Last updated: NA
Last verified: February 2010
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2008
  Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)